CD9:PA:PA-Amundi MSCI Europe High Dividend UCITS (EUR)

ETF | Others |

Last Closing

USD 173.58

Change

0.00 (0.00)%

Market Cap

USD 0.11B

Volume

6.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-01 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.17 (-0.39%)

USD 64.67B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+2.80 (+0.58%)

USD 10.34B
WRD:PA HSBC ETFs Public Limited Compa..

+0.14 (+0.44%)

USD 9.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-0.17 (-0.07%)

USD 7.53B
HHH:PA HSBC ETFs Public Limited Compa..

+0.29 (+0.58%)

USD 6.65B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+3.55 (+0.85%)

USD 6.61B
WLD:PA Lyxor UCITS MSCI World D-EUR

+1.26 (+0.40%)

USD 6.26B
LCWD:PA Multi Units Luxembourg - Lyxor..

+0.07 (+0.43%)

USD 4.96B
500U:PA Amundi Index Solutions - Amund..

+0.63 (+0.61%)

USD 4.44B
WSRI:PA Amundi MSCI World SRI Climate ..

+0.23 (+0.24%)

USD 4.01B

ETFs Containing CD9:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.33% 45% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.33% 48% F 55% F
Trailing 12 Months  
Capital Gain 11.47% 51% F 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.47% 52% F 64% D
Trailing 5 Years  
Capital Gain 41.19% 57% F 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 41.19% 55% F 64% D
Average Annual (5 Year Horizon)  
Capital Gain 7.80% 63% D 62% D
Dividend Return 7.80% 59% D- 61% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.91% 58% F 75% C
Risk Adjusted Return 65.52% 84% B 88% B+
Market Capitalization 0.11B 34% F 48% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.